Co-Founder & President
Prof. Salvatore Albani, MD, PhD
Harnessing human immunity and artificial intelligence to transform scientific discovery into real-world health impact. With more than 25 years at the forefront of translational medicine, Professor Albani bridges academia, innovation, and global policy to accelerate therapies from concept to clinic.
About Professor Albani
Professor Salvatore Albani is an internationally recognised physician-scientist and innovation leader dedicated to understanding and modulating the human immune system to tangibly improve health.
As Founder and Director of the Translational Immunology Institute at Singapore Health Services and Duke-NUS Medical School, he pioneered the integration of artificial intelligence with immunology to extract clinically actionable insights from high-complexity biological data. His work has led to validated predictive models and the identification of novel immune therapeutic targets now advancing toward clinical application.
With an H-index of 61 and recognition among the top 1% of immunologists worldwide (Scopus), Professor Albani’s research is published in leading international journals and has attracted over USD 55 million in competitive funding across Singapore, the United States, and Europe.
At the Eureka Institute for Translational Medicine, which he co-founded and now leads as President, his focus extends further: cultivating a global community of translational leaders capable of bridging science, technology, regulation, industry, and investment to accelerate meaningful health innovation.
Key Highlights:
Pioneer in AI-Driven Immunology. Integrating advanced computational tools with immune biology to accelerate therapeutic discovery.
100+ Patents & 4 Global IND Applications. Inventor of breakthrough technologies progressing toward clinical translation.
USD 55M+ Competitive Funding Secured. Leading large-scale, multinational research initiatives.
Top 1% Immunologist Worldwide. High-impact publications and global scientific recognition.
Architect of Translational Ecosystems. Building international platforms connecting academia, industry, and policy.
Professor Albani is a builder at heart, of therapies, platforms, and people. He brings uncommon drive to translational medicine, with the insistence that ideas must become outcomes. He pushes discovery beyond publication, into targets, programs, and clinical realities, while building passionate talent that accelerates the field globally.
